MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
16.34
+1.39
+9.30%
After Hours: 16.46 +0.12 +0.73% 19:59 02/06 EST
OPEN
15.40
PREV CLOSE
14.95
HIGH
16.35
LOW
15.11
VOLUME
303.83K
TURNOVER
--
52 WEEK HIGH
69.97
52 WEEK LOW
6.76
MARKET CAP
209.05M
P/E (TTM)
-0.8127
1D
5D
1M
3M
1Y
5Y
1D
Tonix Pharma Incorporates Prior Financial Information by Reference
TipRanks · 4d ago
Tonix Pharmaceuticals steigert die Investitionen im Gesamtjahr 2025 auf 3,4 Mio. USD, ein Anstieg um das 34-Fache
Reuters · 4d ago
Tonix Pharma FY25 net cash used in operating activities rises to USD 99.0 million, up 62%
Reuters · 4d ago
Analysts’ Top Healthcare Picks: Tonix Pharma (TNXP), CSPC Pharmaceutical Group (CHJTF)
TipRanks · 5d ago
Weekly Report: what happened at TNXP last week (0126-0130)?
Weekly Report · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer
Reuters · 01/30 18:38
BUZZ-U.S. STOCKS ON THE MOVE-Charter Communications, Western Digital, Regeneron
Reuters · 01/30 15:42
BUZZ-Tonix pain‑relief drug meets main goal in late‑stage study; shares fall
Reuters · 01/30 13:25
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.